Introduction

▼
Obesity is a central factor in pathologies of the metabolic syndrome and associated with increased risk for insulin resistance and type 2 diabetes [ 1 ] . A hallmark of obesity is the ectopic deposition of lipids in nonadipose tissues like the liver and skeletal muscle [ 2 , 3 ] . In the liver, accumulation of lipids and lipid metabolites interferes with insulin sensitivity, leading to increased hepatic glucose production even in the presence of increased insulin levels [ 2 ] . Furthermore, nonalcoholic fatty liver disease (NAFLD) is the fi rst step on the route to nonalcoholic steatohepatitis (NASH) and eventually liver cirrhosis [ 4 ] . In order to identify the genes associated to an increased risk for obesity, numerous genome wide association studies (GWAS) have been conducted. So far, several single nucleotide polymorphisms (SNPs) in genes like FTO , MC4R , and LEPR have been identifi ed that are associated to Although heritability is considered to be a major risk factor, the almost 40 candidate genes identifi ed by genome-wide association studies (GWAS) so far account for only 5-10 % of the observed variance in BMI in human subjects. Alternatively, diet-induced changes of epigenetic gene regulation might be involved in disturbed lipid homeostasis and weight development. The aim of this study was to investigate how a highcarbohydrate diet (HCD; 70 kcal % from carbohydrates, 10 kcal % from fat) or a high-fat diet (HFD; 20 kcal % from carbohydrates, 60 kcal % from fat) aff ects hepatic expression of genes involved in fatty acid metabolism and if these alterations are correlated to changes in promoter methylation. Expression of stearoyl-CoA desaturase 1 ( Scd1 ) was lower in livers from HFD-fed C57BL/6 J mice compared to HCD-fed animals and correlated inversely with the degree of DNA methylation at 2 distinct, adjacent CpG sites in the Scd1 promoter. In contrast, expression of transcription factors peroxisome proliferator activated receptor alpha and gamma ( Ppara , Pparg ), and sterol regulatory element binding transcription factor 1 ( Srebf1 ) was not aff ected. The degree of hepatic Scd1 promoter methylation at these CpG sites correlated positively to fat mass and serum leptin levels, whereas serum ghrelin levels were inversely correlated with methylation at both CpG sites. Taken together, hepatic expression of Scd1 is diff erentially aff ected by carbohydrateand lipid content of the diet. These diff erences in Scd1 expression are associated with altered promoter methylation, indicating that diets aff ect lipid metabolism in the liver via epigenetic mechanisms.
guish between inherited and acquired methylation marks because endogenous factors like nutrition and exercise can aff ect the methylation of multiple genes involved in glucose and lipid metabolism during the lifetime (reviewed in [ 9 ] ). For example, studies in rats revealed that high-fat feeding interferes with hepatic glucose metabolism by methylation and repression of the genes coding for glucokinase and L-type pyruvate kinase [ 10 ] . Besides alterations in glucose metabolism, accumulation of lipids in the liver is an early event in the onset of diet-induced insulin resistance and obesity. Therefore, we aimed at investigating the eff ects of diet on epigenetic regulation of genes involved in fatty acid oxidation and storage. A major regulator of lipid storage in liver and adipose tissue is the enzyme stearoyl-CoA desaturase-1 ( Scd1 ), which introduces a double bond into saturated fatty acids to produce monounsaturated fatty acids (MUFAs) [ 11 ] . This generation of MUFAs is important for the generation of triglycerides and complex lipids, but also involved in cellular signaling, diff erentiation, and apoptosis [ 12 , 13 ] . In Scd1 -/-mice lipogenesis in the liver is reduced in favor of increased beta-oxidation, suggesting an important role of Scd1 in diet-induced obesity [ 14 ] . Interestingly, liver-specifi c knockdown of Scd1 resulted in a protection from carbohydrate-induced, but not from high-fat diet-induced obesity and hepatic steatosis [ 15 ] . Also the combined knockdown of Scd1 in liver and adipose tissue did not protect the mice from high-fat diet-induced obesity [ 16 ] . Together, these data indicate a complex regulation of Scd1 expression and function by dietary factors, particularly carbohydrates. This complexity is further illustrated by confl icting observations regarding high-fat diet-dependent regulation of Scd1 expression. While some researchers found an increase in hepatic Scd1 expression upon feeding mice a HFD [ 17 , 18 ] , others reported a reduced expression of Scd1 [ 19 ] . A human study with obese subjects even found a positive correlation of hepatic Scd1 expression to insulin sensitivity, and a negative correlation to liver fat, suggesting a protective function of Scd1 during obesity [ 20 ] . In this study, we report diet-dependent diff erences in DNA methylation of the hepatic Scd1 promoter that correlate to Scd1 expression and body weight, indicating a novel mechanism of diet-dependent regulation of Scd1 expression and, thus, fatty acid metabolism.
Materials and Methods
▼
Animals and diets
Male C57BL/6 J mice from The Jackson Laboratory (Bar Harbor, USA) were housed in individually-vented cages at a temperature of 21 ± 1 °C with a 12-h light-dark cycle (lights on at 6 AM). After weaning at day 21, the animals received either a high-carbohydrate diet (HCD, 20 kcal % from protein, 70 kcal % from carbohydrate, and 10 kcal % from fat, order number D12450B) (n = 8) or a high-fat diet (HFD, 20 kcal % from protein, 20 kcal % from carbohydrate and 60 kcal % from fat, order number D12492) (n = 8) both from Research Diets (New Brunswick, USA). The detailed diet composition is depicted in • ▶ Table 1 weeks on these diets, the animals were sacrifi ced for tissue preparation and blood collection after a 6-h fasting period. Blood glucose was determined with an Ascensia ELITE XL glucose meter (Bayer Health Care, Leverkusen, Germany). Body composition (fat and lean mass) was measured by nuclear magnetic resonance with an EchoMRI Whole Body Composition Analyzer (Echo Medical Systems, Houston, TX, USA) as previously described [ 21 ] . The mice were housed and handled in accordance with good animal practice as defi ned by FELASA (www.felasa.eu/guidelines.php) and the national animal welfare body GV-SOLAS (www.gv-solas. de/index.html). All animal experiments were approved by the ethics committee of the State Agency of Environment, Health and Consumer Protection (State of Brandenburg, Germany).
RNA preparation, cDNA synthesis, and qRT-PCR
Total RNA from liver tissue of mice was extracted, and cDNA synthesis was performed as described previously [ 22 ] . 18 000 × g and 4 °C, supernatants were collected. Proteins (15 μg) from the supernatants were separated by SDS-PAGE and transferred onto polyvinylidene difl uoride (PVDF) membranes. For immunochemical detection, membranes were incubated with primary antibodies against mouse SCD1 (sc-14719 from Santa Cruz, Dallas, USA) and AKT (# 9272 from Cell Signaling, Danvers, USA) for 16 h at 4 °C, and subsequently with corresponding HRPlinked secondary antibodies (Dianova, Hamburg, Germany) for 1 h at room temperature.
Isolation of genomic DNA and bisulfi te sequencing PCR (BSP)
DNA was isolated using the Invisorb Genomic DNA Kit II from Stratec (Berlin, Germany) according to manufacturer's instructions. Bisulfi te conversion of gDNA was performed using the Cells-to-CpG Kit from Applied Biosystems (Carlsbad, USA) following the manufacturer's instructions. Briefl y, 1 μg of genomic DNA was mixed with Denaturation Reagent and incubated at 50 °C for 10 min. Upon addition of bisulfi te-containing Conversion Reagent, the nonmethylated cytosins of the DNA were converted to thymine using a thermal cycler and multiple heating (95 °C) and cooling (65 °C) steps. After desulfonation of the samples, the DNA was washed and purifi ed. Subsequently, the bisulfi te-converted DNA (bsDNA) was subjected to PCR using bisulfi te-specifi c primers ( • ▶ Table 3 ). Upon purifi cation with the QIAquick PCR Purifi cation Kit from QIAGEN (Hilden, Germany) and sequencing PCR using the BigDye ® Terminator v3.1 Ready
Reaction Mix from Applied Biosystems, the samples were sequenced on a 3130 xl sequencer (Applied Biosystems). For quantifi cation of the degree of methylation per CpG in each PCR fragment, the peak height of cytosine (ph c ) was divided by the sum of the cytosine and thymine (ph c + t ), and multiplied by 100 (ph c /ph c + t × 100) [ 23 ] .
Serum levels of leptin, ghrelin, and insulin
Blood samples were collected after a 6-h fasting period at time of sacrifi ce from vena cava and immediately chilled on ice. After 15 min of centrifugation at 8 000 × g and 4 °C, serum was collected and stored at − 80 °C. Serum leptin levels were measured using a murine ELISA kit from DRG International (Mountainside, USA). For ghrelin measurements blood samples were immediately centrifuged after the addition of AEBSF and EDTA. Plasma was collected and acidifi ed with aqueous 1 N HCl. For quantification of total ghrelin levels a commercially available RIA for Rat/Mouse from Millipore (Billerica, USA) was used. Active ghrelin was measured using the Rat/Mouse Ghrelin ELISA from Milli- pore. Serum insulin levels were measured with the Mouse Ultrasensitive Insulin ELISA kit (ALPCO, Salem, USA). All assays were performed according to the manufacturer's instructions.
Statistics
All data are presented as means ± SEM. Statistical analysis was performed by Student's t -test or linear regression analysis using the software Prism 5 from GraphPad Software (La Jolla, USA). Signifi cance levels were set for p-values of less than 0.05 (*), 0.01 (**) and 0.001 (***).
Results
▼
Carbohydrate and fat content of diet modifi es expression of genes involved in hepatic lipid metabolism
In order to investigate the eff ect of diet composition on hepatic fatty acid metabolism, male C57BL/6J mice received either a high-carbohydrate diet (HCD) or a high-fat diet (HFD) for 18 weeks. Animals receiving HCD had a signifi cantly lower lean and fat mass compared to the animals fed the HFD ( • ▶ Table 4 ). While liver weight did not diff er between the groups, total amounts of liver triglycerides were elevated in the HFD group, but did not reach statistical signifi cance. The amounts of dietary carbohydrates and fatty acids largely infl uence lipid metabolism and might contribute to diff erential methylation and expression of genes involved in fatty acid metabolism. Therefore, we fi rst investigated the expression of genes involved in fatty acid oxidation [acyl-CoA synthetase long-chain family member 1 ( Acsl1 ) , . 2b ). Western blot analysis confi rmed this observation; SCD1 protein levels were higher in livers of mice on the HCD than in livers of the HFD group ( • ▶ Fig. 2c ).
Since Scd1 expression is regulated by the lipogenic transcription factor sterol regulatory element binding protein-1c (SREBP-1c, Srebf1 ) [ 24 ] we analyzed the mRNA levels of diff erent key transcription factors involved in lipid metabolism. Interestingly, we did not fi nd any diff erences in expression of peroxisome proliferator activated receptor alpha and gamma ( Ppara , Pparg ), or sterol regulatory element binding transcription factor 1 ( Srebf1 ) ( • ▶ Fig. 2d ), indicating that hepatic Scd1 expression is not regulated by diff erential expression of its key transcription factor Srebf1 in response to a high-carbohydrate diet, but rather by other mechanisms.
Altered CpG methylation in the Scd1 promoter in liver tissue
Exogenous factors like environmental stress and nutrition can aff ect DNA methylation and persistently infl uence expression of genes involved in whole body energy homeostasis [ 25 , 26 ] . Therefore, we tested if the diff erential hepatic Scd1 expression in HCD versus HFD-fed mice was associated to diff erences in methylation of its promoter region. Using MethPrimer software [ 27 ] we depicted representative CpG-enriched fragments (CpG islands) in the promoter region of Scd1 ( • ▶ Fig. 3a ). Next, we . 3b ).
In the second CpG island ( − 614 to − 230 bp relative to TSS) there was a general low methylation level that was not diff erent between the diet groups ( • ▶ Fig. 3c ). In the third and fourth CpG . 4c ). Taken together, Scd1 gene expression and body weight development is largely correlated to methylation at 2 distinct CpG sites in the liver Scd1 promoter.
Serum leptin and ghrelin levels correlate to methylation of the hepatic Scd1 promoter
The anorexigenic hormone leptin is known to inhibit Scd1 expression, while its counterpart the orexigenic hormone ghrelin is an activator of Scd1 gene expression [ 17 , 28 ] . Furthermore, insulin has been shown to enhance Scd1 expression via activation of SREBP-1c [ 29 ] . Because (i) hepatic Scd1 expression correlated with fat mass and (ii) leptin is produced and secreted by the adipose tissue, we tested if serum leptin levels correlate to the degree of CpG − 838 and CpG − 833 methylation. As expected, CpG site (relative to transcription start site) CpG methylation (%) Fig. 3 Methylation of the hepatic Scd1 promoter. a CpG islands of the Scd1 promoter. CpG content of the promoter region (2 000 bp upstream of transcription start), the 5′-UTR and the CDS was analyzed using MethPrimer Software ( http://www.urogene.org/methprimer ). Areas with a length of more than 200 bp, a GC content of more than 50 % and observed vs. expected CpG ratio of more than 60 % were defi ned as CpG islands. Numbers indicate the positions relative to transcription start site. b -d Single CpG methylation in CpG island 1 b , 2 c , and 3 plus 4 d of the Scd1 promoter upon HCD-feeding (white bars) and HFD-feeding (grey bars), respectively. CpG islands were selectively amplifi ed by BSP and sequenced. Methylation was calculated as the amount of unconverted vs. converted cytosine. Data are mean values ± SEM of 8 animals per group (n = 8). * Statistically diff erent from corresponding basal value with p < 0.05, *** statistically diff erent from corresponding basal value with p < 0.001. serum leptin and insulin levels of the HCD-fed group were low compared to the HFD-fed group (p < 0.01) ( • ▶ Fig. 5a ), indicating impaired insulin sensitivity in the HFD group. On the other hand, levels of total ghrelin, but not active ghrelin, were higher in the HCD group compared to the HFD group (p < 0.05) ( • ▶ Fig. 5a ). Fig. 5b, c ) .
In contrast to leptin and ghrelin, there was no correlation of serum insulin levels to methylation at any of the 2 CpG sites (R 2 = 0.1193 and 0.1632, respectively) ( • ▶ Fig. 5b, c ) . Taken together, serum leptin and ghrelin levels, aff ected by dietary carbohydrate and fat content, are indicative for the methylation and expression of hepatic Scd1 .
Discussion
▼
Hepatic expression of genes involved in fatty acid metabolism is diff erentially aff ected by dietary content of carbohydrates, saturated and unsaturated fatty acids. Amongst these genes we found Scd1 , the gene coding for stearoyl-Coenzyme A desaturase 1, to be substantially weaker expressed in livers from animals that were fed a HFD for 18 weeks, compared to the HCD-fed group. The diff erences in Scd1 expression were independent of mRNA levels of the transcription factors Ppara , Pparg , and Srebf1 . However, the magnitude of Scd1 expression was inversely correlated to the degree of methylation of CpG -838 and CpG -833 in the Scd1 promoter, suggesting that methylation of these 2 CpG sites is involved in the regulation of Scd1 expression by macronutrient composition of the diet. This hypothesis was further strengthened by the observation that total body weight (especially fat mass) is also highly correlated with Scd1 promoter methylation and expression. A possible link between fat mass and Scd1 promoter methylation is leptin, which is known to inhibit Scd1 expression and correlated to methylation of both CpG sites. Hence, methylation of CpG -838 and CpG -833 presents a novel mechanism how macronutrients and hormones might aff ect hepatic Scd1 expression. Major dietary inducers of Scd1 expression in the liver are carbohydrates, while poly-unsaturated fatty acids (PUFAs) are able to blunt this eff ect [ 30 ] . Carbohydrate-dependent induction of Scd1 expression is complex and partly mediated by SREBP-1c and liver X receptor (LXR) [ 31 , 32 ] . SREBP-1c is also transcriptionally activated at elevated insulin levels in a phosphatidylinositol-3-kinase (PI3K)-dependent manner [ 29 ] . Although insulin levels were increased in the HFD group, Srebf1 expression was not altered, indicating impairment of insulin sensitivity by feeding the HFD. This impaired insulin sensitivity could also serve as an explanation why hepatic Scd1 expression was not increased in the hyperinsulinemic HFD group. Besides SREBP-1c, carbohydrate responsive element-binding protein (ChREBP) is activated by acetylation in response to dietary carbohydrates, and subsequently induces Scd1 expression to promote lipogenesis [ 33 ] . In contrast to carbohydrates, PUFAs impair the expression of SREBP-1c by inhibiting the binding of LXR to the Srebf1 promoter [ 34 ] . Furthermore, LXR response ele- ments (LXRE) are also present in the Scd1 promoter and PUFAs might aff ect Scd1 expression independent of SREBP-1c [ 35 ] . However, LXR-dependent inhibition of gene transcription is not likely to be the mechanism behind our observations, as Srebf1 expression was not diff erent between the 2 diet groups. This observation is in line with published data that report a decreased Scd1 expression upon HFD-feeding, independent of Srebf1 expression [ 19 ] . A possible mechanism might include leptin, which has been shown to inhibit Scd1 expression independently of Srebf1 [ 17 ] . Methylation at CpG -838 and CpG -833 adds another layer, how diet and/or body weight might regulate expression of Scd1 . Epigenetic regulation of Scd1 expression in the liver has not yet been studied, however, diet-dependent alterations of promoter methylation are known to aff ect gene expression, for example, of hepatic glucokinase and L-type pyruvate kinase [ 10 ] . Dietinduced alterations of promoter methylation are not liver specifi c and have also been reported for adipose tissue (e. g., leptin) and brain (e. g., melanocortin-4 receptor, tyrosine hydroxylase, and dopamine transporter) [ 25 , 36 , 37 ] . Importantly, the degree of single CpG methylation correlated with Scd1 expression and body weight only for CpG -838 and CpG -833 , while the third differentially methylated CpG site (CpG + 384 ) did not show a clear correlation to Scd1 expression or body weight, suggesting a predominant role in Scd1 expression only for the fi rst 2 CpG sites. Sequence-based analysis of the proximity of CpG -838 and CpG -833 identifi ed recognition sites for hepatic nuclear factors (HNF/ FoxA) and mouse Krueppel like factors (MOK) at these CpG sites. How these 2 families of transcription factors are involved in Scd1 expression is not established yet and will require further investigation. Increased fat mass is associated with increased serum levels of adipocyte-derived leptin, which is a major regulator of satiety [ 38 ] . Besides its anorexigenic function, leptin has also been shown to inhibit Scd1 expression in liver and adipose tissue to promote fatty acid oxidation [ 17 , 39 ] . So far, the exact mechanism is not known and eff ects of leptin on hepatic Scd1 have been suggested to be both indirect via the central nervous system as well as direct on the hepatocyte [ 40 ] . In accordance to the literature, serum leptin levels correlated inversely with expression of Scd1 in the livers of HCD-and HFD-fed mice. However, further research is needed to clarify if increased circulating levels of leptin and methylation of the hepatic Scd1 promoter are independent observations or mechanistically linked. Ghrelin, the orexigenic counterpart of leptin, activates Scd1 expression in adipose tissue via the sympathetic nervous system [ 28 ] . Here, we have reported a similar correlation of circulating ghrelin levels to hepatic Scd1 gene expression and, additionally, to methylation of its promoter. On neuronal level, ghrelin has been shown to activate Sirtuin1 (Sirt1)/p53 and mTOR signaling pathways [ 41 , 42 ] . If these pathways are involved in regulating Scd1 expression in the liver is currently not known. Nevertheless, recent studies indicate a strong and opposing eff ect of leptin and ghrelin on hepatic steatosis and fi brosis, emphasizing their impact on hepatic metabolism independent of their central-nervous function [ 43 , 44 ] . Taken together, these data show that diet composition and body weight development aff ect hepatic Scd1 promoter methylation and gene expression. Furthermore, promoter methylation was tightly linked to serum leptin and ghrelin levels, suggesting a novel mechanism, how both hormones and macronutrients could regulate Scd1 expression and, thus, ectopic lipid accumulation in the liver.
